Literature DB >> 2285627

Twenty-four hour ambulatory blood pressure profile of a new, sustained-release preparation of nicardipine.

P A Broadhurst1, G Brigden, M Heber, A Lahiri, E B Raftery.   

Abstract

The 24-hour blood pressure (BP) profile of a new sustained-release preparation of nicardipine was assessed in 16 patients with essential hypertension (supine cuff diastolic BP greater than 95 mmHg). Twenty-four hour ambulatory intraarterial BP monitoring (Oxford system) before treatment revealed a mean (SD) daytime BP of 174 (19) mmHg systolic and 105 (8) mmHg diastolic, and a mean nighttime BP of 142 (26) mmHg systolic and 83 (12) mmHg diastolic. Sustained release nicardipine (60 mg) was administered twice daily for 4-6 weeks and the ambulatory BP monitoring repeated. No significant change in heart rate occurred throughout the 24-hour period. However, there was a significant reduction (p less than 0.0001) in the mean daytime BP of 21 (13) mmHg systolic and 12 (9) mmHg diastolic and of mean nighttime BP of 21 (5) mmHg systolic and 13 (11) mmHg diastolic. A similar reduction in hourly mean BP occurred throughout the whole 24-hour period, including the steep early morning rise in BP. Although vasodilatory-type side effects occurred, they were generally mild to moderate and transient. This preparation produces a significant reduction in BP throughout the 24-hour period without reflex tachycardia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285627     DOI: 10.1007/bf01857750

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  14 in total

1.  The effects of metoprolol on ambulatory blood pressure.

Authors:  S Mann; M W Craig; D G Altman; D I Melville; E B Raftery
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

2.  Hybrid system for fast data reduction of long-term blood-pressure recordings.

Authors:  P M Cashman; F D Stott; M W Craig
Journal:  Med Biol Eng Comput       Date:  1979-09       Impact factor: 2.602

3.  Effect of once-daily atenolol on ambulatory blood pressure.

Authors:  M W Craig; D Kenny; S Mann; V Balasubramanian; E B Raftery
Journal:  Br Med J       Date:  1979-01-27

4.  Coronary heart-attacks in East London.

Authors:  H T Pedoe; D Clayton; J N Morris; W Brigden; L McDonald
Journal:  Lancet       Date:  1975-11-01       Impact factor: 79.321

5.  Anti-hypertensive dose-response effects of nicardipine in stable essential hypertension.

Authors:  S H Taylor; M A Frais; P Lee; S P Verma; N Jackson; B Silke
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Baroreflex setting and sensitivity after acute and chronic nicardipine therapy.

Authors:  M A Young; R D Watson; W A Littler
Journal:  Clin Sci (Lond)       Date:  1984-02       Impact factor: 6.124

7.  The effect of a new calcium channel blocker nicardipine on 24-hour ambulatory blood pressure and the pressor response to isometric and dynamic exercise.

Authors:  R I Jones; R S Hornung; T Sonecha; E B Raftery
Journal:  J Hypertens       Date:  1983-06       Impact factor: 4.844

8.  Nifedipine tablets for systemic hypertension: a study using continuous ambulatory intraarterial recording.

Authors:  R S Hornung; B A Gould; R I Jones; T N Sonecha; E B Raftery
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

9.  Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study.

Authors:  A Lahiri; C W Robinson; R S Kohli; M P Caruana; E B Raftery
Journal:  Clin Cardiol       Date:  1986-06       Impact factor: 2.882

10.  Diurnal variation in occurrence of strokes.

Authors:  J Marshall
Journal:  Stroke       Date:  1977 Mar-Apr       Impact factor: 7.914

View more
  1 in total

1.  Twenty-four hour ambulatory blood pressure profile of a new slow-release formulation of diltiazem in mild to moderate hypertension.

Authors:  A G Dupont; J M Coupez; P Jensen; R Coupez-Lopinot; D F Schoors; P Hermanns; M Nicolas
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.